Streetbeat News

Products Services

MSOS

At Benzinga's Cannabis Capital Conference, PharmaCann CEO Brett Novey discussed the company's growth across seven states, highlighting their award-winning gummies and vapes. Novey emphasized the strategy of entering new states to collect rewards and build reputation, with the goal of becoming the number one cannabis company in 3-4-5 years.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:38 pm

BYDDY

TSLA

VWAGY

XPEV

Volkswagen AG, in partnership with XPeng Inc, has developed a new EV architecture aimed at reducing manufacturing costs and competing with Tesla Inc. This China Electrical Architecture (CEA) will reduce control units by 40%, targeting a launch in 2026 for Volkswagen-branded EVs in China. This development is part of Volkswagen's strategy to regain its market position in China against local EV makers like BYD Company Limited, which recently expanded its vehicle offerings.

Portfolio Pulse from Upwallstreet

April 17, 2024 | 3:37 pm

SNY

Sanofi SA (NASDAQ:SNY) reported positive Phase 2 study results for its CD40L antibody, frexalimab, in treating relapsing multiple sclerosis. The study showed sustained reduction of disease activity and favorable tolerability after nearly one year. The data revealed significant decreases in lesions and a very low annual relapse rate, with high percentages of patients free of Gd+ T1 lesions at week 48. Frexalimab was well-tolerated, and lymphocyte counts remained stable throughout the study.

Portfolio Pulse from Vandana Singh

April 17, 2024 | 3:37 pm

MSOS

Mario Naric, a representative of a large extraction company, discusses their strategy to target different groups and expand their product set, including a focus on 'Liquid Diamonds' to grow market share. The company is diversifying across more categories and notes the fickleness of the Canadian market. The Cannabis Capital Conference offers live access for subscribers and new users.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:36 pm

ISPR

MSOS

Michael Wang emphasizes the potential of vaping technology to better protect minors compared to traditional smoking methods. He mentions the development of age-gating technology and the involvement of the FDA in its regulation. This technology aims to safeguard minors while making the marketplace more accessible to adults, suggesting that the controversy around flavored vaping products could be mitigated.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:35 pm

MSOS

At Benzinga's Cannabis Capital Conference, Motif Labs CEO & Founder Mario Naric highlighted the company's diverse product range with various flavors, indicating a strong product differentiation in the market. The conference also offers live access for both existing and new subscribers.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:33 pm

MSOS

At the Benzinga Cannabis Capital Conference, Kosmik Brands CFO Paul Vancea discussed the evolving preferences of cannabis consumers towards more subtle consumption methods, such as vapes that can be concealed in nicotine cases, and a shift towards purer cannabis elements. The conference also offers live access for both existing and new subscribers.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:32 pm

DKNG

DraftKings (NASDAQ:DKNG) has seen significant options activity indicating mixed sentiment among big-money investors, with a bullish bias. Benzinga's options scanner revealed 9 unusual trades, split between 55% bullish and 44% bearish. The trades suggest a price target range of $20 to $50 for DKNG. Analysts maintain positive ratings on DKNG, with target prices ranging from $50 to $58. The company is expanding in online sports and casino gambling, now live in multiple states and Canada.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 3:31 pm

ISPR

MSOS

At Benzinga's Cannabis Capital Conference, Ispire CEO Michael Wang emphasized the importance of self-regulation in the cannabis industry, focusing on providing only hardware.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:30 pm

MSOS

The Benzinga Cannabis Capital Conference is currently underway, featuring a segment titled 'Puff To Profit: How A Sneaky Product Snuck Up The Demand Rankings'. This segment aims to explore the rise of a particular cannabis product in the market. Attendees, including existing subscribers, have direct access to the live conference, while new users can gain instant access through a provided link. The ETF MSOS may be discussed in relation to the cannabis market.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:24 pm